Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking approach to diabetes management. These innovative drugs function by mimicking the physiological actions of GLP-1, a hormone produced by the https://baidubookmark.com/story20628679/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes